Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. - Wikidata - awgldk - TriplyDB

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

http://www.wikidata.org/entity/Q37457553

about

The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer Improving the clinical impact of biomaterials in cancer immunotherapy.Evolving immunotherapy strategies in urothelial cancer Efficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tag Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody.Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.Vaccines against human carcinomas: strategies to improve antitumor immune responses.Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines SAPHO syndrome with bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer.Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer Therapeutic cancer vaccines: current status and moving forward.Bladder Cancer Immunotherapy: BCG and Beyond.Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.Emerging intravesical therapies for management of nonmuscle invasive bladder cancer 1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.Investigational therapies for non-muscle invasive bladder cancer.Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies.Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond.Future directions in bladder cancer immunotherapy: towards adaptive immunity.HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response.In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.Biomaterial-based vaccine induces regression of established intracranial glioma in rats.Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice

P2860

Q26738516-BBA3FC54-8522-4662-826D-2505322D15A2 Q26766267-3BDC707A-1BDA-4E15-A025-BA951560250B Q26823557-62D509E8-B3BA-4ED9-A516-06FD53B37CEA Q28655742-BE51C888-1A8B-44AD-AB83-D208AC13EC18 Q33591239-26A87693-1B94-40A3-AE82-51DAAF4430B8 Q33612179-A9581117-F26C-43C8-98DE-13474AE3125D Q33734281-8CFB7D08-833D-4B72-BA16-094E02B0D0B6 Q33745353-8B639A34-40AF-4477-9D6C-D500018C8526 Q33815087-E1100108-3C5B-47E3-9134-51B8571E0F67 Q34241776-F37DCCAD-559B-4671-AA52-993555D7114F Q34356322-D67FB8DB-A4B6-4C97-8F9C-36F7403BE520 Q34523513-37910827-F156-4859-A575-79AE34CE5215 Q35157433-70A0DE11-15A4-44BD-8DD9-38570DA5A806 Q35215350-BCB83453-4105-419B-A54A-4EAA2FE9C9CB Q35690511-118B4EC1-7825-4275-8D70-096D4009568F Q35894347-0B80A034-0831-45E1-99E3-C908C72448BF Q36072179-977712FB-D4B2-4E84-B7CB-64778D4FD968 Q36310762-9A9C1BBF-844C-49C4-8577-EE28F8EC3E62 Q36553255-F773D179-53FC-48F8-B8B0-4954F1353B71 Q36731317-8862149C-B581-4BAC-90A1-D9728A4C2138 Q36939977-EEABF20F-2658-4AB8-96EF-6C63089AF7F7 Q37283563-E8B584D0-546F-41A0-A9A1-E8E9CB22A4FC Q37589142-A79998EA-704F-4379-A8AA-55C23599E1EC Q37616492-D803DC22-E133-4EBD-9CB5-E8B798DD92F8 Q37676223-171A4760-75B3-4833-AB2D-1AAFF029D719 Q38251141-07155E2B-A907-4644-B5BF-555E8173C40E Q38425054-2A86AA73-3B6A-4402-9EAC-F762F84C5670 Q38727522-DA94C226-7170-48C3-BF54-DCF28E489E1C Q39491926-12DD159C-6597-4E9C-AE1C-946B33191E44 Q41518057-D440F17B-E3E9-4A62-99F4-6A94E2A54B7C Q55463511-A9007339-0E99-4C5D-9786-4953DB6F4102 Q58737121-6B1204AB-895A-4378-9C86-50F08F2FCEEB

P2860

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

http://www.wikidata.org/entity/Q37457553

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

@en

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

@nl

type

label

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

@en

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

@nl

prefLabel

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

@en

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

@nl

P1433

Q37457553-526A478F-5D29-4E46-84D6-E9A1C5DE1F5A

P1476

Q37457553-68BC5935-73F3-40FD-BE1F-982515FA79C6

P2093

Q37457553-3012FFC2-F0FE-4B63-BF5E-874912D5705E

Q37457553-5B118C42-532C-4695-AC43-E99C7146B4ED

Q37457553-9E46EC57-8005-4CD7-B654-10ED29820F75

Q37457553-AC63610E-3EE2-4A86-A5F5-831B459486F9

Q37457553-B351D5DD-FC82-4FE2-BBBF-BDF8680EC9B1

Q37457553-C4C3D94D-F94A-40EF-8C74-945FB0AD96BB

Q37457553-EC62D818-A841-45DE-92EB-9E95B0DEDF2A

Q37457553-F3656733-A523-4B65-8EB0-8CE6E2484152

P2860

Q37457553-0C4DA704-4048-418C-9C94-61C92A374595

Q37457553-1DDB9A3B-6E1D-42D9-AAB0-E53A3F7D1224

Q37457553-1FB54623-B486-4720-BFC9-2C3DD36E1EC3

Q37457553-21666112-9A95-41F1-9001-DB9F4D25BA69

Q37457553-2424FAC8-CFE8-4431-9C30-1732DBAA415D

Q37457553-256D7A06-8DCB-4817-A592-D5AAB784451F

Q37457553-261D9276-C04D-4214-8127-234500BFAA9C

Q37457553-2713CD35-282F-44CE-A407-28F6D4015F3F

Q37457553-35A26093-D8BB-478B-9827-B99C9E9B2C3D

Q37457553-4CB94F4D-4DFA-4C12-9877-1A60C6A11F29

P304

Q37457553-BE1941A6-81FF-485C-ADE0-A2DEF1276AB1

P31

Q37457553-82C3D568-A916-4C28-AE9E-9B912DA372D0

P356

Q37457553-8B62CD8A-1526-4F2C-98A7-46591CD79ED2

P407

Q37457553-092237EA-121D-4189-B590-8BDAA16700AC

P433

Q37457553-AC71FEC3-AE7A-4D5B-978C-41134A480957

P478

Q37457553-25825843-7C03-48D0-8264-105B58716049

P50

Q37457553-6D145BE5-E7BD-42F4-9766-C28C4F331CF5

Q37457553-C98AF881-08F6-49DC-A582-84110F176740

P577

Q37457553-883A994E-3096-4AB3-9062-21B24053AC26

P5875

Q37457553-0D5F3B20-4FBA-4035-B14F-13E90B7B7470

P698

Q37457553-CD11137F-6DB8-494F-9512-E4CB58B0414D

P921

Q37457553-7a238e60-d044-4ad9-a0c8-ca0c7131c187

Q37457553-C62A50C8-BA44-4D68-A92E-F816D2756AA6

P932

Q37457553-8501DB2A-DED0-47AA-B2C5-13AC1ABFE402

P356

0008-5472.CAN-09-1114

P1433

Cancer Research

P1476

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12

@en

P2093

Benjamin S Hoffman

http://www.w3.org/2001/XMLSchema#string

Compton J Benjamin

http://www.w3.org/2001/XMLSchema#string

Connie J Rogers

http://www.w3.org/2001/XMLSchema#string

H Brooks Hooper

http://www.w3.org/2001/XMLSchema#string

Jeffrey Schlom

http://www.w3.org/2001/XMLSchema#string

John W Greiner

http://www.w3.org/2001/XMLSchema#string

Kenneth W Hance

http://www.w3.org/2001/XMLSchema#string

Peter A Pinto

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Cancer statistics, 2008

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).

BCG immunotherapy of bladder cancer: 20 years on.

Interleukin-12 in anti-tumor immunity and immunotherapy.

Chitosan-based gastrointestinal delivery systems.

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

Chitosan chemistry and pharmaceutical perspectives.

Chitosan: a versatile biopolymer for orthopaedic tissue-engineering.

The use of mucoadhesive polymers in vaginal delivery.

P304

6192-6199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-1114

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Kiranpreet K Khurana

P577

2009-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26701512

http://www.w3.org/2001/XMLSchema#string

P698

19638573

http://www.w3.org/2001/XMLSchema#string

P921

P932

2788203

http://www.w3.org/2001/XMLSchema#string